Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NOVAPACS, NOVAVIEW, NOVACARDIO, NOVAQC AND NOVAER

K-Number: K061920 · 2006-08-21

ApplicantNovarad Corp.
Decision Date2006-08-21
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

NOVAPACS, NOVAVIEW, NOVACARDIO, NOVAQC AND NOVAER is the device name listed in this FDA 510(k) record. The listed applicant is Novarad Corp.. It received FDA 510(k) clearance on 2006-08-21 under 510(k) number K061920. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NOVAPACS, NOVAVIEW, NOVACARDIO, NOVAQC AND NOVAER?

NOVAPACS, NOVAVIEW, NOVACARDIO, NOVAQC AND NOVAER is a medical device that received FDA 510(k) clearance on 2006-08-21. The listed applicant is Novarad Corp.. The 510(k) number is K061920.

When did NOVAPACS, NOVAVIEW, NOVACARDIO, NOVAQC AND NOVAER receive FDA 510(k) clearance?

NOVAPACS, NOVAVIEW, NOVACARDIO, NOVAQC AND NOVAER received FDA 510(k) clearance on 2006-08-21, under 510(k) number K061920.

Who is the listed applicant for NOVAPACS, NOVAVIEW, NOVACARDIO, NOVAQC AND NOVAER?

The FDA 510(k) record lists Novarad Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NOVAPACS, NOVAVIEW, NOVACARDIO, NOVAQC AND NOVAER?

The FDA product code for NOVAPACS, NOVAVIEW, NOVACARDIO, NOVAQC AND NOVAER is LLZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Novarad Corp. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K063153NOVAPACS

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261874Syneris PACS v.1.0.1.0SynerisK262442HipStudio AnalysisReplasia BVK261855Elucid PlaqueIQElucid Bioimaging, Inc.K254214OOOPDSTaiwan Main Orthopaedic Biotechnology Co., Ltd.K261861SPINEsim v1.0Mdsim S.A.K2620603D-RD-SRadiopharmaceutical Imaging & Dosimetry, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑